Back

Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Atrial fibrillation - Epidemiology prognosis outcome Heart Failure in Atrial Fibrillation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Sergio Jose Dubner

Buenos Aires (Argentina)

9 More presentations in this session

Presentation thumbnail
Doctor B. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Assistant Professor F. Ricci (Chieti, IT)
Abstract Slides
Presentation thumbnail
Professor P. Kirchhof (Hamburg, DE)
Abstract
Presentation thumbnail
Doctor R. Jansen (Alkmaar, NL)
Abstract
Presentation thumbnail
Mr P. Cozzolino (Monza, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Atrial fibrillation - Epidemiology prognosis outcome

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources